Aceto launches generic drugs for infections, malaria

PORT WASHINGTON, N.Y. — A subsidiary of Aceto Corp. has launched two generic drugs for treating infectious diseases, the company said Monday.

Aceto said its Rising Pharmaceuticals subsidiary launched flucytosine capsules, a version of Valeant Pharmaceuticals International's Ancobon, used to treat serious infections; and chloroquine phosphate tablets, a generic version of Sanofi's malaria drug Aralen. The drugs' branded versions had sales of $20 million during the 12-month period ended in June, Aceto said.

"The chloroquine phosphate launch marks the first leveraging of a product by Rising that was brought to them directly as a result of Aceto's worldwide sourcing capabilities," Aceto chairman and CEO Albert Eilender said. "This illustrates the synergistic business opportunities we believe will become more plentiful as we move forward."

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.